Imaging Features (CT, MRI, MRS, PET/CT) of Primary Central Nervous System Lymphoma in Immunocompetent Patients
Neurol Sci 40:535-542, Cheng, G. & Zhang, J., 2019
A Case of Acute Encephalopathy and Rigidity in a 30-Year-Old Man
Neurol 93:759-763, Hurtubise, B. & MacLellan, A., 2019
When MRI is a Clue in Episodic Ataxia
Neurol 93:e2074-e2075, Dhawan, S.R.,et al, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared with Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke
JAMA Neurol 76:774-782, Tillman, H.,et al, 2019
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Cerebral Microbleeds
Neurol 92:e253-e262, Graff-Radford, J.,et al, 2019
Mapping the Supratentorial Cerebral Arterial Territories Using 1160 Large Artery Infarcts
JAMA Neurol 76:72-80, Kim, D-E.,et al, 2019
Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA 32:175-187, Brown, J.W.L.,et al, 2019
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis
JAMA 32:165-174,153, Burt, R.K.,et al, 2019
A 61-Year-Old Woman with Acute Onset Dysgraphia
Neurol 92:e386-e391, Smith, L.R.,et al, 2019
Bismuth Neurotoxicity from Use of Topical Bismuth Dressing for Burns
Neurol 92:680-681, Saini, V.,et al, 2019
Three Territory Sign
Neurol Clin Pract 9:124-128, Nouh, A.M.,et al, 2019
A Woman in her 40s with Transient Neurological Symptoms, Migraine Headaches, and Hearing Loss
JAMA Neurol 76:504-505, Roshal, D.A.,et al, 2019
Lesion Localization of Poststroke Lateropulsion
Stroke 50:1067-1073, Babyar, S.R.,et al, 2019
Clinicopathologic Conference, Ingestion of Isopropyl Alcohol
NEJM 380:1657-1665, Case 13-2019, 2019
Basa Ganglia Calcifications (Fahrs Syndrome): Related Conditions and Clinical Features
Neurol Sci 40:2251-2263, Donzuso,G.,et al, 2019
Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018
Clinicopathologic Conference, Homocystinuria due to genetic mutations of the gene encoding cystathionine B-synthase (CBS)
NEJM 378:941-948, Case 7-2018, 2018
Mixed-Location Cerebral Hemorrhage/Microbleeds
Neurol 90:e119-e126, Pasi, M.,et al, 2018
Gasperini Syndrome
Neurol 90:e261, Lorio, R., 2018
Supplementary Motor Area Stroke Mimicking Functional Disorder
Stroke 49:e28-e30, Mathew, P.,et al, 2018
Headache and Altered Mental Status
Neurol 90:e1267-e1270, Spera, K.M.,et al, 2018
Acute Amnestic Syndrome Associated with Fentanyl Overdose
NEJM 378:1157-1158, Barash, J.A., et al, 2018
Acute acalculous cholecystitis
Neurol 90:e1548-e1552, Croteau, D.,et al, 2018
Distinct Brain Microhemorrhage Pattern in Critical Illness Associated with Respiratory Failure
Neurol 90:e2011, Hall, J.P.,et al, 2018
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
NEJM 379:1017-1027, Chitnis, T.,et al, 2018
Large Vessel Occlusion in Acute Stroke
Stroke 49:2323-2329, Beume, L.A.,et al, 2018
Wilson Disease
NIDDK Oct2018, , 2018
Cerebral Fat Embolism Syndrome in Sickle Cell Disease Without Evidence of Shunt
eNeurologicSci 14:19-20, Nathan, C.L.,et al, 2018
Pyruvate Dehydrogenase Deficiency (PDCD)
eMedicine.medscape,com, Aug, Frye,R.E.,et al, 2018
Intracranial Meningeal Enhancement Characterization
Rev Colomb Radiol 28:4709-4716, Mera, J.L.C.,et al, 2017
Cerebral Venous Sinus Thrombosis in Homocystinuria: Dietary Intervention in Conjunction with Anticoagulation
Sage Open Med Case Reports 5:1-4, Yap, S.,et al, 2017
Evolution of DWI lesions in Cerebral Amyloid Angiopathy
Neurol 89:2136-2142, Van Veluw, S.J.,et al, 2017
Imaging Characteristics of Venous Parenchymal Abnormalities
Stroke 48:3258-3265, Arnoux, A.,et al, 2017
Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
Lancet 390:2481-2489, Green, A.J.,et al, 2017
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017
Have Clinicians Adopted the Use of Brain MRI for Patients with TIA and Minor Stroke?
Neurol 88:237-244, Chaturvedi, S.,et al, 2017
Disparities and Guideline Adherence in Drugs of Abuse Screening in Intracerebral Hemorrhage
Neurol 88:252-258, Tomoehlen, L.M.,et al, 2017
A Young Woman with Respiratory Failure, Hearing Loss, and Paraplegia
Neurol 88:e78-e84, Ntranos, A.,et al, 2017
Clinicopathologic Conference, Primary Adrenal Insufficiency (Addisons Disease)
NEJM 376:1159-1167, Case 9-2017, 2017
Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017
Diagnosis of Multiple Sclerosis: Progress and Challenges
Lancet 389:1336-1346, Brownlee, W.J.,et al, 2017
Long-Term Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
JAMA Neurol 74:459-469,392, Muraro, P.A.,et al, 2017
Primary Angiitis of the Central Nervous System
Stroke 48:1248-1255, Boulouis, G.,et al, 2017
A 45-year-old man with Weakness and Myalgia after Orthopedic Surgery
Neurol 88:e185-e189, Vazquez do Campo, R.,et al, 2017
Distribution of Lacunes in Cerebral Amyloid Angiopathy and Hypertensive Small Vessel Disease
Neurol 88:2162-2168, Pasi, M.,et al, 2017
Dentate Update: Imaging Features of Entities that Affect the Dentate Nucleus
AJNR 38:1467-1474, Bond, K.M.,et al, 2017
Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017
Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017